Ethics & Compliance Officer Association, University of Chicago to Co-Sponsor Event on the Financial Impact of Ethics and Compliance Programs.

WALTHAM, Mass. -- The Ethics & Compliance Officer Association (ECOA), in conjunction with the University of Chicago Graduate Business School and in collaboration with the Harvard University's School of Public Health, will convene a meeting of corporate stakeholders to kick off a research project on the financial value of corporate ethics and compliance programs. The event is chaired by L. Stephan Vincze, V.P., Ethics and Compliance Officer, TAP Pharmaceuticals, and William Ott, Principal, PEAC Ventures, Inc. Confirmed participants include Wal-Mart, TAP Pharmaceuticals, Boeing, and Johnson & Johnson.

This highly interactive one day meeting, which will take place October 24-25 at the University of Chicago, will include two parts: brief formal remarks on key topics made by select thought leaders, and an opportunity for participants to provide input and feedback in response to those remarks. Confirmed speakers for the day include David Shore, Dean of the Harvard School of Public Health, Ann Cato, V.P. and Chief Ethics Officer, Wal-Mart Inc., and Georgia Keresty, V.P. Worldwide Healthcare Compliance, Johnson & Johnson. Agenda topics for the day include government perspective, as well as the impact of ethics, compliance, governance, and corporate culture on the bottom line. Feedback provided by participants will be used to focus an in depth research project on the value of ethics and compliance programs. Research will be conducted jointly by the University of Chicago and Harvard under the auspices of the ECOA. Registration for this event is limited; for more information please contact the ECOA at 781-647-9333. For information on other upcoming ECOA events, please visit www.theecoa.org.